Supplementary Data from Identification of Common Predictive Markers of &lt;i&gt;In vitro&lt;/i&gt; Response to the Mek Inhibitor Selumetinib (AZD6244; ARRY-142886) in Human Breast Cancer and Non–Small Cell Lung Cancer Cell Lines